EP1293568A4 - Nouvelle proteine et son adn - Google Patents

Nouvelle proteine et son adn

Info

Publication number
EP1293568A4
EP1293568A4 EP01941123A EP01941123A EP1293568A4 EP 1293568 A4 EP1293568 A4 EP 1293568A4 EP 01941123 A EP01941123 A EP 01941123A EP 01941123 A EP01941123 A EP 01941123A EP 1293568 A4 EP1293568 A4 EP 1293568A4
Authority
EP
European Patent Office
Prior art keywords
dna
novel protein
protein
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01941123A
Other languages
German (de)
English (en)
Other versions
EP1293568A1 (fr
Inventor
Tomofumi Kurokawa
Takao Yamada
Shigeto Morimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of EP1293568A1 publication Critical patent/EP1293568A1/fr
Publication of EP1293568A4 publication Critical patent/EP1293568A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP01941123A 2000-06-21 2001-06-20 Nouvelle proteine et son adn Withdrawn EP1293568A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000191088 2000-06-21
JP2000191088 2000-06-21
PCT/JP2001/005263 WO2001098495A1 (fr) 2000-06-21 2001-06-20 Nouvelle proteine et son adn

Publications (2)

Publication Number Publication Date
EP1293568A1 EP1293568A1 (fr) 2003-03-19
EP1293568A4 true EP1293568A4 (fr) 2005-10-26

Family

ID=18690444

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01941123A Withdrawn EP1293568A4 (fr) 2000-06-21 2001-06-20 Nouvelle proteine et son adn

Country Status (4)

Country Link
US (1) US20030175808A1 (fr)
EP (1) EP1293568A4 (fr)
AU (1) AU2001274566A1 (fr)
WO (1) WO2001098495A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE381618T1 (de) * 1999-11-04 2008-01-15 Univ London Polypeptidhormon phosphatonin
US6790639B2 (en) * 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
DE10064827A1 (de) * 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US20070099822A1 (en) * 2003-09-19 2007-05-03 Rowe Peter S Regulation of tissue mineralization and phosphate metabolism by asarm peptides
US20050118727A1 (en) * 2003-12-01 2005-06-02 Carsten Schelp Conjugates and their use in detection methods
EP1695083A1 (fr) 2003-12-01 2006-08-30 Dade Behring Marburg GmbH Procede de detection homogene
CA2621167A1 (fr) * 2005-08-30 2007-03-08 Acologix, Inc. Regulation du metabolisme mineral et squelettique
WO2007032559A1 (fr) * 2005-09-15 2007-03-22 Osaka University Nouvel anticorps monoclonal et utilisation de celui-ci
JPWO2007032560A1 (ja) * 2005-09-15 2009-03-19 国立大学法人大阪大学 新規モノクローナル抗体及びその用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010078A2 (fr) * 1996-09-05 1998-03-12 Karaplis Andrew C Clonage d'adnc pleine longueur de pex humain
WO2000018954A2 (fr) * 1998-09-28 2000-04-06 Mcgill University Utilisation de pex dans le traitement de maladies metaboliques des os

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
US6673900B2 (en) * 1999-11-04 2004-01-06 University College London Polypeptide hormone-phosphatonin
JP4424575B2 (ja) * 1998-05-18 2010-03-03 ユニバーシティー カレッジ ロンドン 新規ポリペプチドホルモン・フォスファトニン

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010078A2 (fr) * 1996-09-05 1998-03-12 Karaplis Andrew C Clonage d'adnc pleine longueur de pex humain
WO2000018954A2 (fr) * 1998-09-28 2000-04-06 Mcgill University Utilisation de pex dans le traitement de maladies metaboliques des os

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KUMAR R: "NEW CONCEPTS CONCERNING THE REGULATION OF RENAL PHOSPHATE EXCRETION", NEWS IN PHYSIOLOGICAL SCIENCES, THE UNION AND THE SOCIETY, MARYLAND, US, vol. 12, October 1997 (1997-10-01), pages 211 - 214, XP001002143, ISSN: 0886-1714 *
KUMAR R: "PHOSPHATONIN-A NEW PHOSPHATURETIC HORMONE? (LESSONS FROM TUMOUR-INDUCED OSTEOMALACIA AND X-LINKED HYPOPHOSPHATAEMIA)", NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIVERSITY PRESS, GB, vol. 12, no. 1, 1997, pages 11 - 13, XP001002177, ISSN: 0931-0509 *
ROWE P S N ET AL: "MEPE, a New Gene Expressed in Bone Marrow and Tumors Causing Osteomalacia", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 67, no. 1, 1 July 2000 (2000-07-01), pages 54 - 68, XP004439324, ISSN: 0888-7543 *
ROWE P S N: "THE PEX GENE: ITS ROLE IN X-LINKED RICKETS, OSTEOMALACIA, AND BONE MINERAL METABOLISM", EXPERIMENTAL NEPHROLOGY, KARGER, DE, vol. 5, 1997, pages 355 - 363, XP000862824, ISSN: 1018-7782 *
ROWE P S N: "THE ROLE OF THE PHEX GENE (PEX) IN FAMILIES WITH X-LINKED HYPOPHOSPHATAEMIC RICKETS", CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, RAPID SCIENCE, LONDON, GB, vol. 7, no. 4, 1998, pages 367 - 376, XP001002174, ISSN: 1062-4813 *
See also references of WO0198495A1 *

Also Published As

Publication number Publication date
EP1293568A1 (fr) 2003-03-19
US20030175808A1 (en) 2003-09-18
AU2001274566A1 (en) 2002-01-02
WO2001098495A1 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1424392A4 (fr) Nouvelles proteines de secretion et adn associe
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1357186A4 (fr) Nouvelles proteines et adn correspondant
EP1186615A4 (fr) Proteine et adn de cette proteine
EP1293568A4 (fr) Nouvelle proteine et son adn
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
GB0021008D0 (en) Protein and nucleic acid sequence
GB0020952D0 (en) Genes and proteins and their uses
EP1293510A4 (fr) Nouveau polypeptide et son adn
AU2225401A (en) Novel protein and dna thereof
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1142999A4 (fr) Proteine et adn associe
EP1428877A4 (fr) Nouvelle proteine et adn associe
EP1447411A4 (fr) Nouvelle proteine, son adn et son utilisation
EP1274716A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1457557A4 (fr) Nouvelles proteines et adn correspondants
EP1111047A4 (fr) Nouvelle proteine et son adn
HUP0300489A3 (en) Novel protein and gene encoding the same
EP1300467A4 (fr) Nouveau polypeptide et adn correspondant
AU2002215208A1 (en) Novel protein and dna thereof
AU2002225372A1 (en) Novel proteins and dnas thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030103

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MORIMOTO, SHIGETO

Inventor name: YAMADA, TAKAO

Inventor name: KUROKAWA, TOMOFUMI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20050913

18W Application withdrawn

Effective date: 20050916